Immunomedics, Dako deal

Dako received a royalty-bearing, non-exclusive license to IMMU's patents covering specific antibodies to carcinoembryonic antigen (CEA) for use in pathology laboratories that stain tumor specimens for CEA. Dako sells reagents for diagnostic pathology. ...